Company intelligence / Profile preview

ITI Life Sciences

Dundee, Scotland, United Kingdom

Ownership: Private
Development stage: Other

Overview

ITI Life Sciences is a publicly funded research and technology commercialization organization rather than a traditional biotech company developing its own pipeline. It funds and manages R&D programs, then licenses developed technologies to commercial partners. Most notably, it licensed stem cell technology to Cellartis AB and developed drug discovery platforms in the UPS and kinase spaces.

Therapeutic areas: ImmunologyEndocrinologyCardiovascularNeurologyInfectious DiseasesOncology
Modalities: Stem cell technologysynthetic biology enabling technologiesdrug discovery platforms
Industry: Drug Discovery Services

Partnerships

Cellartis AB (stem cell technology licensee)University of GlasgowUniversity of DundeeHeriot-Watt University (research providers)

Beyond the preview

Go deeper on ITI Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ITI Life Sciences.

Explore the full profile